Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Prognostic Value of Non-Nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Working Group Database.

Annals of surgical oncology·2026
Same author

Publisher Correction: Prognostic Value of Non-nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Working Group Database.

Annals of surgical oncology·2026
Same author

Prognostic Value of Non-nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Working Group Database.

Annals of surgical oncology·2026
Same author

External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsy.

The British journal of surgery·2025
Same author

An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.

Annals of surgical oncology·2025
Same author

A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockade.

Melanoma research·2025
Same journal

Complete Response of Merkel Cell Carcinoma to Immunotherapy and Single-Fraction Radiotherapy Following Severe COVID-19 Infection: A Case Report and Review of Immune Mechanism.

The American surgeon·2026
Same journal

Perioperative Acute Myocardial Infarction in Non-Cardiac Operations: A National Analysis.

The American surgeon·2026
Same journal

Outcomes of Completion Cholecystectomy: Association With Patient Comorbidity in a National Database.

The American surgeon·2026
Same journal

Building the Conversation: Editorial Stewardship in Contemporary Surgical Publishing.

The American surgeon·2026
Same journal

Musculoskeletal Pain in Surgeons on Operating Days.

The American surgeon·2026
Same journal

Splenectomy During Cytoreductive Surgery: Marker of Surgical Burden or Independent Predictor of Morbidity?

The American surgeon·2026
See all related articles

Related Experiment Video

Updated: Jun 29, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.8K

Stage-Based Detection Methods and Recurrence Patterns for Cutaneous Melanoma.

F Grace Sullivan1, Keith B Adler1, Madeleine D Boudreaux1

  • 1Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, AL, USA.

The American Surgeon
|March 29, 2024
PubMed
Summary
This summary is machine-generated.

Melanoma recurrence varies by stage. Patient-reported symptoms and imaging effectively detect recurrences, with imaging crucial for advanced stages. Early detection aids melanoma surveillance.

Keywords:
melanomasurgical oncology

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.7K
Quantitative Visualization and Detection of Skin Cancer Using Dynamic Thermal Imaging
06:08

Quantitative Visualization and Detection of Skin Cancer Using Dynamic Thermal Imaging

Published on: May 5, 2011

16.8K

Related Experiment Videos

Last Updated: Jun 29, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.8K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.7K
Quantitative Visualization and Detection of Skin Cancer Using Dynamic Thermal Imaging
06:08

Quantitative Visualization and Detection of Skin Cancer Using Dynamic Thermal Imaging

Published on: May 5, 2011

16.8K

Area of Science:

  • Oncology
  • Dermatology
  • Medical Imaging

Background:

  • Melanoma surveillance guidelines lack standardization.
  • Understanding melanoma recurrence patterns is crucial for effective patient management.
  • Current detection methods include patient complaint (PC), physical exam (PE), cross-sectional imaging (CSI), and ultrasound (US).

Purpose of the Study:

  • To analyze melanoma recurrence patterns across different stages.
  • To evaluate the effectiveness of various detection methods for melanoma recurrence.
  • To inform optimal melanoma surveillance strategies.

Main Methods:

  • Retrospective review of 276 resected melanoma patients (Stage I, II, III).
  • Analysis of recurrence detection using PC, PE, CSI, and US.
  • Correlation of recurrence rates and detection methods with disease stage.

Main Results:

  • Recurrence rates were 8% (Stage I), 24% (Stage II), and 27% (Stage III).
  • Patient complaint was the primary detection method for Stage I (55%), while CSI was key for Stages II (45%) and III (59%).
  • Recurrence patterns shifted from local (Stage I) to regional and distant (Stages II and III).

Conclusions:

  • History and physical (H&P) are essential for all melanoma patients.
  • Cross-sectional imaging is a vital surveillance tool, particularly for higher-stage melanoma.
  • Tailored surveillance strategies based on stage are recommended for optimal melanoma recurrence detection.